Adenovirus36 infection expresses cellular APMI and Visfatin genes in overweight Uygur individuals by Yi Jiao et al.
Jiao et al. Diagnostic Pathology 2014, 9:83
http://www.diagnosticpathology.org/content/9/1/83RESEARCH Open AccessAdenovirus36 infection expresses cellular APMI
and Visfatin genes in overweight Uygur individuals
Yi Jiao1, Xinmin Mao2, Xi Chang1, Kelimu Abudureyimu3, Cheng Zhang3, Jianfei Lu1, Yanjiao Wang1,
Nuerbiye Nuermaimaiti1, Yiliyasi Aisa1, Xian Gong1 and Yaqun Guan1*Abstract
Objective: This study is to determine if Adenovirus type 36 (Ad36) infection is related to macrophage infiltration in
the obese group and non-obese group and the related molecular mechanisms.
Methods: Ninety obesity patients and 95 non-obesity Uygur individuals were enrolled in this study. CD68 levels in
abdominal subcutaneous and omental adipose tissues were detected by immunohistochemistry. The cytokine
expression levels of adiponectin (APMI) and visfatin in serum were measured by enzyme-linked immunosorbent
assay. Infection of 3T3-L1 cells with Ad36 was performed. Real-time PCR was performed to determine expression
levels of APMI and Visfatin genes in the 3T3-L1 preadipocytes infected with Ad36.
Results: In the obese individuals infected with Ad36, the expression levels of adiponectin and visfatin in serum was
elevated. For the individuals infected with Ad36, the macrophage infiltration (as indicated by CD68 level) in the obese
group was also significantly higher than that in the non-obese group (P < 0.05) in both abdominal subcutaneous and
omental adipose tissues. The real-time PCR results indicated that APMI mRNA levels and Visfatin mRNA levels in Ad36
infected cells were significantly increased.
Conclusions: Ad36 infection may be a factor related with macrophage infiltration in adipose tissues of the obese
patients. The APMI and Visfatin genes may be involved in the mechanism underlying the effect of Ad36 infection on
the obese patients.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1849614638119816
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Obesity has become a severe public health problem in
the world and affects people across various ethnicities in
all countries [1]. Obesity is defined as excessive body fat
accumulation that presents a risk to health. According
to the Asia-Pacific adult obesity criteria, body mass index
(BMI, a person’s weight divided by the square of his or her
height) < 25 kg/m2 was considered as normal and BMI ≥
25 kg/m2 was indicated as obese. Obesity increases the
likelihoods of various diseases, especially heart disease, type
2 diabetes, sleep apnea, and some kinds of tumors [2-4].
Although obesity is usually resulted from a combination of* Correspondence: miranda812@163.com
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unless otherwise stated.excessive food intake and lack of physical exercises, it may
be affected by factors involved in the metabolic processes,
such as adiponectin and visfatin. Adiponectin, encoded by
APMI gene, is a protein hormone that modulates meta-
bolic processes, including glucose regulation and fatty acid
oxidation [5]. It plays an important role in regulating body
fat percentage, glucose level and lipid metabolism [6]. In
adults, adiponectin level is inversely correlated with BMI,
waist circumference (WC), body fat percentage and fasting
plasma insulin concentration. In patients with obesity, type
2 diabetes or coronary artery disease, plasma adiponectin
concentration is significantly reduced [7]. Visfatin is a pro-
tein secreted by visceral adipose tissue and has insulin-like
metabolic effects on glucose metabolism [8]. Studies found
that serum visfatin levels are increased in individuals with
abdominal obesity and correlate strongly with the amount. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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increase of visfatin in obesity may be a counterregulation
preventing further glucose increase.
In addition, some infectious factors may be related to
obesity [11,12]. It is reported that Adenovirus type 36
(Ad36) infection is associated with obesity. For example,
Pasarica et al. [13] found that Ad-36 induced lipid accu-
mulation in primary human adipose-derived stem/stro-
mal cells (hASC). By using serum neutralization assay,
Atkinson et al. [14] found that 30% of obese and 11% of
non-obese humans have neutralizing antibodies to Ad36.
These results indicate that Ad-36 plays a role in the eti-
ology of human obesity. However, the underlying cellular
and molecular mechanism of Ad36 in human obesity is
still unclear. One of the Ad36 viral genes, E4orf1, is thought
to be involved in the mechanism underlying virus-induced
obesity by increasing adipocyte differentiation factors [15].
However, whether other factors regulating body fat such as
adiponectin and visfatin are also involved in Ad36-induced
obesity is unknown and needs further investigation.
We found that a big portion of the long-term obese
Uighur residents in Xinjiang region, China were naturally
infected with Adenovirus type 36 (Ad36). In this study, we
aimed to determine if Ad36 infection was related to obesity
in Uighur residents in Xinjiang region and the underlying
mechanisms. Obese individuals and non-obese controls
who were long-term Uighur residents in Xinjiang region,
China were enrolled. Biochemical indices were compared
between obese and non-obese individuals (with or without
Ad-36 infection). The macrophage infiltration (as indicated
by CD68 level) in abdominal subcutaneous and omental
adipose tissues was analyzed. The level of adiponectin and
visfatin in the serum and the mRNA expression of adipo-
nectin and visfatin in 3T3-L1 preadipocytes infected with
Ad36 were also investigated.Materials and methods
Patients
Ninety obesity patients and 95 non-obesity Uygur in-
dividuals were enrolled in this study. According to
the Asia-Pacific adult obesity criteria, body mass index
(BMI) < 25 kg/m2 was considered as normal and BMI ≥
25 kg/m2 was indicated as obese. The age range of the
individuals was 30-70 years old. All individuals enrolled
in this study were long-term Uighur residents in Xinjiang
region, China. There were no blood relationships among
them. Individuals with the following characteristics were
excluded: (i) artery or peripheral vascular disease; (ii) thy-
roid dysfunction; (iii) acute inflammatory and trauma and
other emergency situation, and (iv) malignancies and a
history of alcohol or drugs. All studies were conducted
under the hospital ethics committee approval and in-
formed consent from every individual was obtained. Thestudy was approved by the ethics review board of Xinjiang
Uygur Autonomous Regional People’s Hospital.
Specimen collection
To determine microphage infiltration in adipose tissue,
biopsy of abdominal subcutaneous and omental adipose
tissues was performed. Briefly, abdominal subcutaneous
and omental adipose tissues were obtained by surgical bi-
opsy from the periumbilical area, under local anesthesia
(1% xylocaine). First, the skin was cleaned and covered
with special surgical drapes. An incision of < 0.5 cm was
made with a plain scalpel to access the subcutaneous and
omental adipose tissues. About 500 mg adipose tissues
was then removed, washed in sterile saline solution,
placed immediately in liquid nitrogen, and stored at -80°C
until analysis. The skin incision was then closed with ab-
sorbable suture material.
Venous blood (5 mL) was also collected from cubital
vein. The serum isolated from venous blood was used for
detection of biochemical indices.
Analysis of biochemical indices
Cholesterol oxidase test with sensitivity of 0.08 mmol/L
was performed to test the total cholesterol (TC). Poly-
ethylene sulfate test with sensitivity of 0.078 mmol/L
was performed to test low density lipoprotein cholesterol
(LDL-C) levels. Enzymatic assay test was performed to
determine the triglyceride (TG) (Sensitivity: 0.05 mmol/L)
and high density lipoprotein cholesterol (HDL-C) (Sensi-
tivity: 0.01 mmol/L). Glucose oxidase-peroxidase-coupled
method with sensitivity of 0.11 mmol/L was used to meas-
ure the fasting blood glucose (FBG) levels.
Enzyme-linked immunosorbent assay (ELISA)
The human serum cytokine concentrations of adiponectin
and visfatin were measured by ELISA kit purchased from
Beijing Aidi Bo biological products company (Beijing,
China). The optical density of each well was determined
by a microplate reader at a wave length of 450 nm. Stand-
ard curve was generated to calculate the concentration of
each sample.
Immunohistochemical staining
Adipose tissue was dehydrated and embedded to make
paraffin section. Primary antibodies against CD68 (1:50)
was used. Hematoxylin staining was performed. Five views
were randomly selected under light microscope from each
slice. Image-pro plus 6.0 software analysis was used to
process the results. The total OD values indicating CD68
expression levels were calculated.
Ad36 infection
The 3T3-L1 preadipocytes were infected with adenoviruses
for 1 h with a titer of 3.8 MOI or 7.6 MOI or mock
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performed in triplicates. After infection, the cells were
cultured in complete DMEM containing 10% fetal bovine
serum and 1% penicillin-streptomycin (Sigma-Aldrich,
USA) in an incubator with the condition of 37°C and 5%
CO2. The complete medium was changed every two days.
At day 1, 3, 5, and 7 days after infection the viruses were
collected, respectively, for further analyses.Quantitative reverse transcription-PCR (RT-PCR)
The total RNA was isolated from Ad36 infected preadi-
pocytes using Trizol (Invitrogen Corporation, USA). The
RT-PCR experiments were repeated at least 3 times. RNA
(1 μg) was reverse-transcribed into cDNA using Oligo (dT)
15 in a reverse transcription II system (Promega, Madison,
WI, USA), according to the manufacturer’s instructions. Ex-
pression of mRNAs was quantified by quantitative PCR
using an ABI Prism Sequence Detection System (Applied
Biosystems). Primers for β-actin, APMI,Visfatin and E4orf1
genes were given in Table 1. Template-negative and RT-
negative conditions were used as controls. Gene amplifi-
cation was monitored using the ABI 7500 software. The
corresponding amplification plots were used to deter-
mine the threshold cycle value. And the threshold cycle
value was defined as the number of PCR cycles taken
for fluorescent intensity to reach a fixed threshold for each
signal. The relative amounts of APMI,Visfatin and E4orf1
mRNA were normalized to the amount of β-actin mRNA
in the same sample.Statistical analyses
The experimental data were given as mean ± standard
error (SEM). Statistical software (SPSS15.0, Chicago, IL,
USA) was used for independent sample t test, followed by
one-way variance analysis. Levels of mRNA transcripts
were analyzed with t-test by SPSS15.0 statistical software.
P < 0.05 indicated a significant difference.Table 1 Primers used in this study










Clinical characteristics, biochemical indices, and changes
in cytokine expression levels in the obese and
non-obese group
To investigate the differences in the obese and non-
obese groups, the data of body mass index (BMI), waist
circumference (WC), hip circumference (HC), diastolic
blood pressure (DBP), systolic blood pressure (SBP), FBG,
TC, TG, HDL-C, LDL-C, adiponectin, and visfatin between
the two groups were compared (Table 2). Compared with
non-obese group, obese group had significantly higher
levels of BMI, WC, HC, DBP, TC, TG and visfatin (P <
0.05). However, the serum levels of adiponectin in the obese
group were significantly lower than the levels in the non-
obese group (P < 0.05).
In non-obese group (n = 95), there were 57 individuals
without Ad36 infection and 38 individuals with Ad36 in-
fection. In obese group (n = 90), there were 37 patients
without Ad36 infection and 53 patients with Ad36 infec-
tion. The difference in biochemical indices and in cyto-
kine expression levels between obese patients with and
without Ad36 was further analyzed. As shown in Table 2,
in non-obese group, serum visfatin level in non-obese
subgroup with Ad36-infection was significantly higher
than that in non-obese subgroup without Ad36-infection
(P < 0.05). In the obese group, the serum levels of TG,
adiponectin and visfatin were significantly different be-
tween the obese individuals infected with Ad36 or not
(P < 0.05). The TG levels in Ad36-infected obese subgroup
were significantly decreased, while serum levels of adipo-
nectin and visfatin in Ad36-infected obese subgroup were
significantly increased. These results indicate that Ad36
infection induces elevated levels of adiponectin and visfa-
tin and improved TG level in the obese individuals.
The comparison of macrophage infiltration between the
obese and non-obese group
In the subcutaneous adipose tissues of the obese and
non-obese group, macrophage infiltration levels as indi-
cated by the CD68 OD values (Table 3) in the obese group
(14294.53 ± 2235.86) were higher than those in the non-
obese group (10867.55 ± 2239.87). The difference was
statistically significant (P < 0.05). For the individuals in-
fected with Ad36, the macrophage infiltration in the obese
group (14730.16 ± 2227.39) was also significantly higher
than those (12258.06 ± 1025.58) in the non-obese group
(P < 0.05).
In the omental adipose tissues (Table 3, Figure 1) of the
obese and non-obese group, the levels of macrophage in-
filtration in the obese group were significantly higher than
those in the non-obese group, but the difference was not
statistically significant (P > 0.05). For the individuals in-
fected with Ad36, the macrophage infiltration levels in the
obese group were significantly higher than those in the
Table 2 Clinical characteristics and biochemical indices in the obese and non-obese groups (mean ± SEM)
Parameters Non-obese group & Obese group# Non-obese group Obese group
Ad36 (-) subgroup Ad36 (+) subgroup Ad36 (-) subgroup Ad36 (+) subgroup
Case number 95 90 57 38 37 53
Age 50 ± 10 53 ± 8 50 ± 10 49 ± 11 52 ± 8 54 ± 8
BMI (kg/m2) 22.4 ± 2.1 29.7 ± 3.7* 22.5 ± 2.3 22.3 ± 1.8 29.8 ± 3.9 29.6 ± 3.6
WC (cm) 84.6 ± 9.8 99.8 ± 8.4* 84.8 ± 10.5 84.5 ± 8.9 100.0 ± 8.2 99.5 ± 8.6
HC (cm) 95.5 ± 5.6 108.2 ± 8.0* 95.6 ± 4.9 95.3 ± 6.7 107.4 ± 8.2 108.9 ± 7.8
DBP (mmHg) 73.4 ± 10.6 80.9 ± 16.8* 73.5 ± 11.6 73.2 ± 9.1 81.2 ± 18.6 80.6 ± 15.3
SBP (mmHg) 118.2 ± 16.20 124.8 ± 21.2 119.2 ± 18.2 116.5 ± 12.8 125.2 ± 20.9 124.5 ± 21.7
FBG (mmol/L) 5.75 ± 2.09 5.82 ± 1.40 6.02 ± 2.40 5.35 ± 1.47 5.98 ± 1.71 6.04 ± 2.37
TC (mmol/L) 4.00 ± 0.84 4.34 ± 0.72* 3.95 ± 0.85 4.09 ± 0.85 4.37 ± 0.75 4.33 ± 0.69
TG (mmol/L) 1.42 ± 0.90 1.81 ± 0.88* 1.35 ± 0.96 1.51 ± 0.81 2.05 ± 1.15 1.59 ± 0.47**
HDL-C (mmol/L) 1.35 ± 0.60 1.28 ± 0.58 1.25 ± 0.37 1.50 ± 0.81 1.28 ± 0.58 1.29 ± 0.60
LDL-C (mmol/L) 2.28 ± 0.75 2.43 ± 0.65 2.23 ± 0.86 2.34 ± 0.56 2.34 ± 0.64 2.51 ± 0.65
Adiponectin (ng/ml) 0.59 ± 0.24 0.49 ± 0.15* 0.57 ± 0.24 0.62 ± 0.23 0.45 ± 0.13 0.54 ± 0.16**
Visfatin (ng/ml) 1.07 ± 0.39 1.23 ± 0.35* 0.98 ± 0.37 1.21 ± 0.40** 1.11 ± 0.35 1.32 ± 0.30**
Note: &, includes the Ad36 (-) non-obese subgroup and Ad36 (+) non-obese subgroup.
#, includes the Ad36 (-) obese subgroup and Ad36 (+) obese subgroup.
*, P < 0.05, when compared with the non-obese group.
**, P < 0.05, when compared with Ad36 (-) non-obese subgroup or Ad36 (-) obese subgroup, respectively.
BMI, body mass index. WC, waist circumference. HC, hip circumference. DBP, diastolic blood pressure. SBP, systolic blood pressure. FBG, fasting blood glucose.
TC, total cholesterol. TG, triglyceride. HDL-C, high-density lipoprotein cholesterol. LDL-C, low-density lipoprotein cholesterol.
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significant (P < 0.05). These results suggest that Ad36 in-
fection may be a factor related with macrophage infiltra-
tion of the obese group and non-obese group.Infection with Ad36 increases expression of APMI and
Visfatin genes in preadipocytes
To further investigate the relationship of Ad36 infection
with obese, the effect of Ad36 infection on 3T3-L1 preadi-
pocytes was determined. Adenoviruses with titers of 3.8
MOI or 7.6 MOI were used to infect the cells, respect-
ively. The mock-infected cells were used as the negative
controls. Real-time quantitative PCR was performed to
detect mouse β-actin, adiponectin, visfatin and E4orf1
mRNA levels. β-actin served as an internal control.Table 3 Levels (OD values) of CD68 in subcutaneous adipose
non-obese groups (mean ± SEM)




10867.55 ± 2239.87 14294.53± 2235.86* 10928.35 ± 18
Omental
adipose tissue
9316.35 ± 1172.26 12982.64 ± 1929.89 9332.27 ± 10
Note: &, includes the Ad36 (-) non-obese subgroup and Ad36 (+) non-obese subgro
#, includes the Ad36 (-) obese subgroup and Ad36 (+) obese subgroup.
*, P < 0.05, when compared with the non-obese group.
**, P < 0.05, when compared with Ad36 (-) non-obese subgroup or Ad36 n-) obeseAs shown in Figure 2, at days 1 to 7, expression of
E4orf1 gene was increased, indicating that the 3T3-L1
preadipocytes were infected with Ad36 (Figure 2A). In-
fection of 3T3-L1 cells with Ad36 (3.8 MOI) suggested
that APMI mRNA levels and Visfatin mRNA levels were
increased from the day 3 and day 4 post-infection, re-
spectively (Figure 2B and 2C) (P < 0.05). Infection of
3T3-L1 cells with Ad36 (7.6 MOI) suggested that APMI
mRNA levels and Visfatin mRNA levels were more sig-
nificantly increased from the day 3 and day 4 post-
infection, respectively (Figure 2D and 2E). These results
show that infection of preadipocytes with Ad36 increases
gene expression of APMI and Visfatin genes, suggesting
that APMI and Visfatin genes may be involved in the
mechanism underlying the effect of Ad36 infection on
the obese patients.tissues and omental adipose tissues in the the obese and
n-obese group Obese group
roup Ad36 (+) subgroup Ad36 (-) subgroup Ad36 (+) subgroup
17.56 12258.06 ± 1025.58 10786.50 ± 2772.80 14730.16 ± 2227.39**
96.35 12914.70 ± 2132.08 11723.17 ± 2888.25 12685.47 ± 1729.52**
up.
subgroup, respectively.
Figure 1 CD68 expression in macrophages in the omental adipose tissues. Adipose tissue was dehydrated and embedded to make paraffin
section. Primary antibodies against CD68 (1:50) was used. Hematoxylin staining was performed (400 ×). Arrows indicated positive CD68-staining.
(A) Ad36 (+); (B) Ad36(+), obese; (C) Ad36(+), non-obese; (D) Ad36 (-); (E) Ad36(-), obese; (F) Ad36(-), non-obese.
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Obesity is an important disease in some regions, such as
the Xinjiang region, China. It directly and indirectly in-
creases the likelihoods of various diseases [2-4,16,17]. Thus
it is of great importance to identify the related factors of
obesity and to investigate the underlying mechanisms. It is
found that human Ad36 increases adiposity in several ani-
mal models, including rodents and non-human primates
[18,19]. Since Ad36 is associated with human obesity, it is
important to determine the relationship between its infec-
tion and obesity [20,21]. In this study, the relationship be-
tween Ad36 infection and obesity and the underlying
mechanism of Ad36 in obesity was investigated.
Our results showed that, in the obese group, the serum
levels of TG, adiponectin and visfatin were found to be
significantly different between the obese individuals in-
fected with Ad36 or not. The TG levels in Ad36-infected
obese subgroup were decreased, while serum levels of adi-
ponectin and visfatin in Ad36-infected obese subgroupFigure 2 Quantitative RT-PCR detection of APMI and Visfatin genes in
infected with Ad36 (3.8 MOI or 7.6 MOI). The mock-infected cells were used
after infection. The total RNAs were extracted and quantitative RT-PCR was
3.8 MOI or 7.6 MOI were used to infect the cells, respectively. (A) E4orf1 exp
mRNA levels in cells infected with Ad36 of 3.8 MOI; (C) Visfatin mRNA level
infected with Ad36 of 7.6 MOI; (E) Visfatin mRNA levels in cells infected witwere increased. The results suggest that in the obese indi-
viduals infected with Ad36, the expression of adiponectin
in serum was elevated and thus TG levels were improved.
Previous studies have shown that Ad-36 infection is asso-
ciated with reductions in serum TC and TG both in adults
and children [14,22]. Thus, our data in obese patients
from Xinjiang region were consistent with previous re-
ports. And, our data further confirmed that Ad36 was re-
lated with obesity, suggesting that Ad36 might be involved
in the etiology of obesity.
Studies have shown that inflammation contributes to
the maintenance of the obesity state and that Ad36 may
maintain the obesity state by inducing inflammation
[23-25]. Adipose tissue in obese subjects is character-
ized by macrophage infiltration [26]. Thus, to determine
whether Ad36 induces macrophage infiltration in adi-
pose tissue, we detected the expression of CD68 in both
abdominal subcutaneous and omental adipose tissues
by immunohistochemistry. The expression of CD68 ispreadipocytes infected with Ad36. The 3T3-L1 preadipocytes were
as the negative controls. The cells were harvested at day 1, 3, 5, 7 days
performed to determine the mRNA levels. Adenoviruses with titers of
ression levels in cells infected with Ad36 (3.8 MOI or 7.6 MOI); (B) APMI
s in cells infected with Ad36 of 3.8 MOI; (D) APMI mRNA levels in cells
h Ad36 of 7.6 MOI.
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that, in the individuals with Ad36 infection, the macro-
phage infiltration in the obese group was also significantly
higher than that in the non-obese group in both abdominal
subcutaneous and omental adipose tissues. Our results,
which were consistent with previous reports, indicate that
macrophage infiltration may be involved in Ad36 induced
obesity.
Ad36 infection accelerates the differentiation of preadi-
pocytes to adipocytes in 3T3-L1 cells and human preadi-
pocytes [13,27]. Although Ad36 E4orf1 gene is thought to
be involved in the mechanism underlying virus-induced
obesity, other related molecular factors are undetermined.
As previously reported [5-10], adiponectin and visfatin are
two important factors involved in obesity. Our results
showed that serum levels of adiponectin and visfatin were
significantly increased in obese patients infected with
Ad36. Thus, to investigate whether adiponectin and visfa-
tin are involved in Ad36-induced obesity, real-time PCR
was performed to determine expression levels of APMI
and Visfatin genes in the 3T3-L1 preadipocytes infected
with Ad36. The expression of Ad-36 E4orf1 gene was in-
creased, indicating that the 3T3-L1 preadipocytes were
infected with Ad36. Infection of 3T3-L1 cells with Ad36
suggested that APMI mRNA levels and Visfatin mRNA
levels were increased from the day 3 and day 4 post-
infection, respectively. These results indicate that infection
of preadipocytes with Ad36 increases gene expression of
APMI and Visfatin genes, and further suggest that APMI
and Visfatin genes may be involved in the mechanism
underlying the effect of Ad36 infection on the obese
patients. The mechanisms underlying the effect of Ad36
infection will be further investigated in the future.
In summary, our data showed that Ad36 was associ-
ated with obesity of patients from Xinjiang region. And,
Ad36 infection may be a factor related with macrophage
infiltration in adipose tissues of the obese patients. In
addition, increased levels of adiponectin and visfatin might
be the mechanisms underlying the effect of Ad36 infection
on obesity.
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